InvestorsHub Logo
Followers 44
Posts 12767
Boards Moderated 0
Alias Born 11/18/2016

Re: sd21 post# 11469

Friday, 01/20/2017 5:13:20 PM

Friday, January 20, 2017 5:13:20 PM

Post# of 108192
Total nonsense. The street's biotech analysts do not get "convinced" or "unconvinced" of a biotech's viability by its CEO. They review clinical trial results and analyze the biotech market in which the company's products would compete. ADXS's trial results, and the market for its vaccines, are both fantastic. Nice try, though.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News